By NOF, Washington, DC; Friday, March 23, 2007

Latest Developments in Osteoporosis Prevention, Diagnosis and Treatment to be Unveiled at Washington, DC Conference

Washington, DC (March 23, 2007) – The National Osteoporosis Foundation (NOF) will bring together a faculty of internationally-renowned experts to announce and discuss new developments in the prevention, diagnosis and treatment of osteoporosis at its comprehensive annual five-day conference in Washington, DC. 


Improvements in identification of osteoporosis and fracture risk, results of several clinical drug trials to treat various types of osteoporosis and affects on other conditions, and studies on effects of vitamin D to prevent and slow osteoporosis and other causes of falling will be presented at the NOF’s 7th International Symposium on Osteoporosis: Translating Clinical Research Into Practice.

EVENT:

7th International Symposium on Osteoporosis:
Translating Clinical Research Into Practice

WHEN:

April 18 – 22, 2007

FEATURED
SPEAKER:

Mark McClellan, MD, PhD Thursday, April 19 at 8 a.m.

WHERE:

 Marriott Wardman Park Hotel
2660 Woodley Road, NW
Washington, DC 20008


For the complete conference agenda, list of speakers, session topics and times, please visit the NOF Web site at www.nof.org. For pre-conference interviews, information and media registration, please contact Lisa Wolfington at 240-620-7934.

The latest

FDA Determines Risks of Calcitonin Outweigh Benefits

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

Washington Post Article Offers Clarity on the Risks and Benefits of Calcium and Vitamin D

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA Partners with NOF

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.

Explore by tag